Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The measles virus nucleoprotein (N) is a structural viral protein that encapsidates the single-stranded negative-sense RNA genome at a ratio of 1 N per 6 ribonucleotides, forming a helical ribonucleocapsid (NC) that protects the genome from nucleases and serves as the template for viral RNA transcription and replication.[1][5][7][11] N consists of an ordered N_CORE domain (residues 1-391 or ~400), comprising N-terminal (NTD) and C-terminal (CTD) domains with flanking N- and C-terminal arms, and an intrinsically disordered N_TAIL domain (residues ~392-525) that anchors the polymerase complex.[1][5][9] The phosphoprotein (P) chaperones RNA-free N^0 to prevent non-specific cellular RNA binding, facilitating transfer to nascent NC during replication; structural studies show P's N-terminal region binding N_CORE to regulate this.[1][2][3][10] N assembles into helical NC following the "rule of six" nucleotides per protomer, with specific RNA-binding grooves and inter-protomer arm interactions stabilizing the structure.[6][9][11] N and P form liquid-like phase-separated droplets that accelerate nucleocapsid assembly.[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Measles virus nucleoprotein (N).